Mariner’s Maravai LifeSciences MRVI Stock Holding History

Mariner’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-37,949	Closed	-$207K	–	3538
2024 Q4	$207K	Sell	37,949 -38,212	-50%	-$246K	﹤0.01%	2972
2024 Q3	$633K	Sell	76,161 -10,608	-12%	-$91.7K	﹤0.01%	1946
2024 Q2	$621K	Sell	86,769 -17,453	-17%	-$151K	﹤0.01%	1886
2024 Q1	$904K	Buy	104,222 +13,135	+14%	+$88.9K	﹤0.01%	1575
2023 Q4	$597K	Buy	91,087 +71,603	+367%	+$463K	﹤0.01%	1829
2023 Q3	$195K	Buy	19,484 +5,757	+42%	+$63.2K	﹤0.01%	2517
2023 Q2	$171K	Sell	13,727 -2,920	-18%	-$39.4K	﹤0.01%	2512
2023 Q1	$233K	Buy	+16,647	New	+$239K	﹤0.01%	2279

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Mariner's MRVI Position: Q1 2025 in Review

Mariner sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 37,949 shares — an estimated $207K sold.

Mariner first reported a position in MRVI in Q1 2023 and held it in 8 quarters. The position peaked at $904K in Q1 2024. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

Mariner reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
Mariner sold 37,949 Maravai LifeSciences shares in Q1 2025, an estimated $207K.
Mariner first reported a position in Maravai LifeSciences in Q1 2023 and held it in 8 quarters.
Mariner's Maravai LifeSciences position peaked at $904K in Q1 2024.
184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on Mariner's 13F filing for Q1 2025, filed 15 May 2025.